These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24650312)

  • 1. Bioresorbable scaffolds in peripheral arterial disease.
    Kassimis G; Spiliopoulos S; Katsanos K; Tsetis D; Krokidis ME
    Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):443-50. PubMed ID: 24650312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective.
    Kraak RP; Grundeken MJ; Koch KT; de Winter RJ; Wykrzykowska JJ
    Expert Rev Med Devices; 2014 Sep; 11(5):467-80. PubMed ID: 25087771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.
    Ielasi A; Tespili M
    Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives.
    Kitabata H; Waksman R; Warnack B
    Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The bioresorbable coronary stent: a revolution].
    Koegler F; De Benedetti E
    Rev Med Suisse; 2013 Apr; 9(381):775-8. PubMed ID: 23659156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioresorbable scaffolds in the treatment of coronary artery disease.
    Zhang Y; Bourantas CV; Farooq V; Muramatsu T; Diletti R; Onuma Y; Garcia-Garcia HM; Serruys PW
    Med Devices (Auckl); 2013; 6():37-48. PubMed ID: 23662091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.
    Tenekecioglu E; Bourantas C; Abdelghani M; Zeng Y; Silva RC; Tateishi H; Sotomi Y; Onuma Y; Yılmaz M; Serruys PW
    Expert Rev Med Devices; 2016; 13(3):271-86. PubMed ID: 26782080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioresorbable scaffold technologies.
    Onuma Y; Ormiston J; Serruys PW
    Circ J; 2011; 75(3):509-20. PubMed ID: 21301138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting bioresorbable scaffolds in cardiovascular disease, peripheral artery and gastrointestinal fields: a clinical update.
    Kawashima H; Ono M; Kogame N; Takahashi K; Chang CC; Hara H; Gao C; Wang R; Tomaniak M; Modolo R; Wykrzykowska JJ; De Winter RJ; Sharif F; Serruys PW; Onuma Y
    Expert Opin Drug Deliv; 2020 Jul; 17(7):931-945. PubMed ID: 32456554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary stents: historical development, current status and future directions.
    Iqbal J; Gunn J; Serruys PW
    Br Med Bull; 2013; 106():193-211. PubMed ID: 23532779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of bioresorbable scaffold failure.
    Felix C; Everaert B; Jepson N; Tamburino C; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V175-80. PubMed ID: 25983160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioabsorbable scaffolds for the treatment of obstructive coronary artery disease: the next revolution in coronary intervention?
    Patel N; Banning AP
    Heart; 2013 Sep; 99(17):1236-43. PubMed ID: 23474621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the "no more metallic cages" multicentre pilot experience.
    Ielasi A; Miyazaki T; Geraci S; Testa L; Abdel-Wahab M; Kawamoto H; Ruparelia N; Sato T; Caramanno G; Bedogni F; Tespili M; Colombo A; Latib A
    EuroIntervention; 2016 Apr; 11(14):e1589-95. PubMed ID: 27056119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioresorbable scaffolds: talking about a new interventional revolution [corrected].
    Hassell ME; Grundeken MJ; Delewi R; Wykrzykowska JJ; Piek JJ
    Minerva Cardioangiol; 2013 Apr; 61(2):165-79. PubMed ID: 23492600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological aspects of bioresorbable stent implantation.
    Sanchez OD; Yahagi K; Byrne RA; Mori H; Zarpak R; Wittchow E; Foin N; Virmani R; Joner M
    EuroIntervention; 2015; 11 Suppl V():V159-65. PubMed ID: 25983157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Innovations in Drug-Eluting Stents for Peripheral Arterial Disease.
    Altit R; Gray WA
    Curr Cardiol Rep; 2017 Oct; 19(11):117. PubMed ID: 29027096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking into the future with bioresorbable vascular scaffolds.
    Costopoulos C; Naganuma T; Latib A; Colombo A
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1407-16. PubMed ID: 24138526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.